Filed
Pursuant to Rule 433
Registration Statement 333-141729
900,000,000
4.55% Notes Due 2017
Pfizer Inc.
May 9, 2007
Pricing Term Sheet
|
|
|
Issuer:
|
|
Pfizer Inc. |
Size:
|
|
900,000,000 |
Maturity:
|
|
May 15, 2017 |
Coupon:
|
|
4.55% annually, accruing from May 14, 2007 |
Price to JPMorgan
|
|
99.551% of principal amount |
Interest Payment Dates:
|
|
May 15, commencing on May 15, 2008 |
Optional Redemption:
|
|
At any time for an amount equal to the principal
amount of the notes redeemed plus a make-whole
premium and accrued but unpaid interest to the
redemption date |
Make-Whole Premium:
|
|
Bund, flat |
Denominations:
|
|
Minimum of 50,000 principal amount and integral
multiples of 1,000 |
Settlement Date:
|
|
May 14, 2007 |
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting
EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer
participating in the offering will arrange to send you the prospectus if you request it by calling
JPMorgan collect at 1-212-834-4533.
This pricing term sheet supplements the preliminary form of prospectus supplement issued by Pfizer
Inc. on May 9, 2007 relating to its Prospectus dated March 30, 2007.